Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells

Jung Min Song, Jintaek Im, Richard S Nho, Yong Hwan Han, Pramod Upadhyaya, Fekadu Kassie

Research output: Contribution to journalArticle

Abstract

Although members of the hyaluronan (HA)-CD44/HA-mediated motility receptor (RHAMM) signaling pathway have been shown to be overexpressed in lung cancer, their role in lung tumorigenesis is unclear. In the present study, we first determined levels of HA and its receptors CD44 and RHAMM in human non-small cell lung cancer (NSCLC) cells and stromal cells as well as mouse lung tumors. Subsequently, we examined the role of HA-CD44/RHAMM signaling pathway in mediating the proliferation and survival of NSCLC cells and the cross-talk between NSCLC cells and normal human lung fibroblasts (NHLFs)/lung cancer-associated fibroblasts (LCAFs). The highest levels of HA and CD44 were observed in NHLFs/LCAFs followed by NSCLC cells, whereas THP-1 monocytes/macrophages showed negligible levels of both HA and CD44. Simultaneous silencing of HA synthase 2 (HAS2) and HAS3 or CD44 and RHAMM suppressed cell proliferation and survival as well as the EGFR/AKT/ERK signaling pathway. Exogenous HA partially rescued the defect in cell proliferation and survival. Moreover, conditioned media (CM) generated by NHLFs/LCAFs enhanced the proliferation of NSCLC cells in a HA-dependent manner as treatment of NHLFs and LCAFs with HAS2 siRNA, 4-methylumbelliferone, an inhibitor of HASs, LY2228820, an inhibitor of p38MAPK, or treatment of A549 cells with CD44 blocking antibody suppressed the effects of the CM. Upon incubation in CM generated by A549 cells or THP-1 macrophages, NHLFs/LCAFs secreted higher concentrations of HA. Overall, our findings indicate that targeting the HA-CD44/RHAMM signaling pathway could be a promising approach for the prevention and therapy of lung cancer.

Original languageEnglish (US)
Pages (from-to)321-333
Number of pages13
JournalMolecular Carcinogenesis
Volume58
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Hyaluronic Acid
Lung Neoplasms
Cell Survival
Cell Proliferation
Non-Small Cell Lung Carcinoma
Lung
Fibroblasts
Conditioned Culture Medium
LY2228820
Hymecromone
Macrophages
CD44 Antigens
Blocking Antibodies
MAP Kinase Signaling System
Stromal Cells
Small Interfering RNA
Monocytes
Carcinogenesis
Cancer-Associated Fibroblasts
Survival

Keywords

  • CD44
  • hyaluronan
  • hyaluronan-mediated motility receptor
  • lung cancer-associated fibroblasts
  • non-small cell lung cancer

Cite this

Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells. / Song, Jung Min; Im, Jintaek; Nho, Richard S; Han, Yong Hwan; Upadhyaya, Pramod; Kassie, Fekadu.

In: Molecular Carcinogenesis, Vol. 58, No. 3, 01.03.2019, p. 321-333.

Research output: Contribution to journalArticle

@article{b7f79ff07e9a4d5fbbd73501a278a7ca,
title = "Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells",
abstract = "Although members of the hyaluronan (HA)-CD44/HA-mediated motility receptor (RHAMM) signaling pathway have been shown to be overexpressed in lung cancer, their role in lung tumorigenesis is unclear. In the present study, we first determined levels of HA and its receptors CD44 and RHAMM in human non-small cell lung cancer (NSCLC) cells and stromal cells as well as mouse lung tumors. Subsequently, we examined the role of HA-CD44/RHAMM signaling pathway in mediating the proliferation and survival of NSCLC cells and the cross-talk between NSCLC cells and normal human lung fibroblasts (NHLFs)/lung cancer-associated fibroblasts (LCAFs). The highest levels of HA and CD44 were observed in NHLFs/LCAFs followed by NSCLC cells, whereas THP-1 monocytes/macrophages showed negligible levels of both HA and CD44. Simultaneous silencing of HA synthase 2 (HAS2) and HAS3 or CD44 and RHAMM suppressed cell proliferation and survival as well as the EGFR/AKT/ERK signaling pathway. Exogenous HA partially rescued the defect in cell proliferation and survival. Moreover, conditioned media (CM) generated by NHLFs/LCAFs enhanced the proliferation of NSCLC cells in a HA-dependent manner as treatment of NHLFs and LCAFs with HAS2 siRNA, 4-methylumbelliferone, an inhibitor of HASs, LY2228820, an inhibitor of p38MAPK, or treatment of A549 cells with CD44 blocking antibody suppressed the effects of the CM. Upon incubation in CM generated by A549 cells or THP-1 macrophages, NHLFs/LCAFs secreted higher concentrations of HA. Overall, our findings indicate that targeting the HA-CD44/RHAMM signaling pathway could be a promising approach for the prevention and therapy of lung cancer.",
keywords = "CD44, hyaluronan, hyaluronan-mediated motility receptor, lung cancer-associated fibroblasts, non-small cell lung cancer",
author = "Song, {Jung Min} and Jintaek Im and Nho, {Richard S} and Han, {Yong Hwan} and Pramod Upadhyaya and Fekadu Kassie",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/mc.22930",
language = "English (US)",
volume = "58",
pages = "321--333",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells

AU - Song, Jung Min

AU - Im, Jintaek

AU - Nho, Richard S

AU - Han, Yong Hwan

AU - Upadhyaya, Pramod

AU - Kassie, Fekadu

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Although members of the hyaluronan (HA)-CD44/HA-mediated motility receptor (RHAMM) signaling pathway have been shown to be overexpressed in lung cancer, their role in lung tumorigenesis is unclear. In the present study, we first determined levels of HA and its receptors CD44 and RHAMM in human non-small cell lung cancer (NSCLC) cells and stromal cells as well as mouse lung tumors. Subsequently, we examined the role of HA-CD44/RHAMM signaling pathway in mediating the proliferation and survival of NSCLC cells and the cross-talk between NSCLC cells and normal human lung fibroblasts (NHLFs)/lung cancer-associated fibroblasts (LCAFs). The highest levels of HA and CD44 were observed in NHLFs/LCAFs followed by NSCLC cells, whereas THP-1 monocytes/macrophages showed negligible levels of both HA and CD44. Simultaneous silencing of HA synthase 2 (HAS2) and HAS3 or CD44 and RHAMM suppressed cell proliferation and survival as well as the EGFR/AKT/ERK signaling pathway. Exogenous HA partially rescued the defect in cell proliferation and survival. Moreover, conditioned media (CM) generated by NHLFs/LCAFs enhanced the proliferation of NSCLC cells in a HA-dependent manner as treatment of NHLFs and LCAFs with HAS2 siRNA, 4-methylumbelliferone, an inhibitor of HASs, LY2228820, an inhibitor of p38MAPK, or treatment of A549 cells with CD44 blocking antibody suppressed the effects of the CM. Upon incubation in CM generated by A549 cells or THP-1 macrophages, NHLFs/LCAFs secreted higher concentrations of HA. Overall, our findings indicate that targeting the HA-CD44/RHAMM signaling pathway could be a promising approach for the prevention and therapy of lung cancer.

AB - Although members of the hyaluronan (HA)-CD44/HA-mediated motility receptor (RHAMM) signaling pathway have been shown to be overexpressed in lung cancer, their role in lung tumorigenesis is unclear. In the present study, we first determined levels of HA and its receptors CD44 and RHAMM in human non-small cell lung cancer (NSCLC) cells and stromal cells as well as mouse lung tumors. Subsequently, we examined the role of HA-CD44/RHAMM signaling pathway in mediating the proliferation and survival of NSCLC cells and the cross-talk between NSCLC cells and normal human lung fibroblasts (NHLFs)/lung cancer-associated fibroblasts (LCAFs). The highest levels of HA and CD44 were observed in NHLFs/LCAFs followed by NSCLC cells, whereas THP-1 monocytes/macrophages showed negligible levels of both HA and CD44. Simultaneous silencing of HA synthase 2 (HAS2) and HAS3 or CD44 and RHAMM suppressed cell proliferation and survival as well as the EGFR/AKT/ERK signaling pathway. Exogenous HA partially rescued the defect in cell proliferation and survival. Moreover, conditioned media (CM) generated by NHLFs/LCAFs enhanced the proliferation of NSCLC cells in a HA-dependent manner as treatment of NHLFs and LCAFs with HAS2 siRNA, 4-methylumbelliferone, an inhibitor of HASs, LY2228820, an inhibitor of p38MAPK, or treatment of A549 cells with CD44 blocking antibody suppressed the effects of the CM. Upon incubation in CM generated by A549 cells or THP-1 macrophages, NHLFs/LCAFs secreted higher concentrations of HA. Overall, our findings indicate that targeting the HA-CD44/RHAMM signaling pathway could be a promising approach for the prevention and therapy of lung cancer.

KW - CD44

KW - hyaluronan

KW - hyaluronan-mediated motility receptor

KW - lung cancer-associated fibroblasts

KW - non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85056359273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056359273&partnerID=8YFLogxK

U2 - 10.1002/mc.22930

DO - 10.1002/mc.22930

M3 - Article

VL - 58

SP - 321

EP - 333

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 3

ER -